NL7904755A - Fenylpiperazinederivaten, werkwijze ter bereiding hiervan en toepassing van dit derivaat in een farma- ceutisch middel. - Google Patents

Fenylpiperazinederivaten, werkwijze ter bereiding hiervan en toepassing van dit derivaat in een farma- ceutisch middel.

Info

Publication number
NL7904755A
NL7904755A NL7904755A NL7904755A NL7904755A NL 7904755 A NL7904755 A NL 7904755A NL 7904755 A NL7904755 A NL 7904755A NL 7904755 A NL7904755 A NL 7904755A NL 7904755 A NL7904755 A NL 7904755A
Authority
NL
Netherlands
Prior art keywords
ceutic
pharma
derivative
preparation
product
Prior art date
Application number
NL7904755A
Other languages
English (en)
Dutch (nl)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7818352A external-priority patent/FR2429216A1/fr
Priority claimed from FR7818351A external-priority patent/FR2429212A1/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of NL7904755A publication Critical patent/NL7904755A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7904755A 1978-06-20 1979-06-19 Fenylpiperazinederivaten, werkwijze ter bereiding hiervan en toepassing van dit derivaat in een farma- ceutisch middel. NL7904755A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7818352A FR2429216A1 (fr) 1978-06-20 1978-06-20 Derives de phenylpiperazine, leur preparation et leur application en therapeutique
FR7818351A FR2429212A1 (fr) 1978-06-20 1978-06-20 Derives de phenylpiperazine et leur application en therapeutique

Publications (1)

Publication Number Publication Date
NL7904755A true NL7904755A (nl) 1979-12-27

Family

ID=26220635

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7904755A NL7904755A (nl) 1978-06-20 1979-06-19 Fenylpiperazinederivaten, werkwijze ter bereiding hiervan en toepassing van dit derivaat in een farma- ceutisch middel.

Country Status (15)

Country Link
AU (1) AU521110B2 (fr)
DE (1) DE2924681A1 (fr)
DK (1) DK251079A (fr)
ES (1) ES481632A1 (fr)
FI (1) FI791926A7 (fr)
GB (1) GB2023594B (fr)
GR (1) GR67646B (fr)
IL (1) IL57569A0 (fr)
IT (1) IT1121588B (fr)
LU (1) LU81396A1 (fr)
NL (1) NL7904755A (fr)
NO (1) NO792020L (fr)
NZ (1) NZ190758A (fr)
PT (1) PT69775A (fr)
SE (1) SE7905402L (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4456756A (en) * 1981-08-03 1984-06-26 Mead Johnson & Company Spirothiazolidinyl piperazine derivatives
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines
US4668687A (en) * 1984-07-23 1987-05-26 Bristol-Myers Company Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones
GB8427125D0 (en) * 1984-10-26 1984-12-05 Lundbeck & Co As H Organic compounds
US5098904A (en) * 1990-06-27 1992-03-24 Bristol-Myers Squibb Company Cerebral function enhancing pyrimidinyl derivatives
ZA918221B (en) * 1990-10-23 1992-06-24 Akzo Nv 4-(4-or 6-(trifluoromethyl-2-pyridinyl))-1-piperazinyl-alkyl substituted lactams
CA2067475C (fr) * 1991-05-08 2000-10-10 Yasuo Oshiro Derives du carbostyrile et leurs utilisations
IT1251144B (it) * 1991-07-30 1995-05-04 Boehringer Ingelheim Italia Derivati del benzimidazolone
EP0911330B1 (fr) * 1997-10-22 2007-12-12 Council of Scientific & Industrial Research 1-(4-Arylpipérazin-1-yl)-3-(2-oxopyrrolidin/pipéridin-1-yl)propanes comme agents thérapeutiques pour l'hypertension, l'ischémie, des troubles cardiovasculaires et d'autres troubles liés aux récepteurs adrénergiques
DE69736291T2 (de) * 1997-10-22 2006-11-23 Council Of Scientific And Industrial Research Verfahren zur Synthese von 1-(4-Arylpiperazin-1-yl)-3-(oxopyrrolidin/piperidin-1-yl)propanen als therapeutische Mittel bei Bluthochdruck, Ischämie, kardiovaskulären und anderen, mit adrenergenen Rezeptoren im Zusammenhang stehenden Störungen
US7183410B2 (en) 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
ES2646326T3 (es) 2005-08-03 2017-12-13 Sprout Pharmaceuticals, Inc. Uso de flibanserina en el tratamiento de la obesidad
CA2626134C (fr) 2005-10-29 2013-12-24 Boehringer Ingelheim International Gmbh Derives de benzimidazolone utiles pour le traitement des troubles premenstruels et d'autres troubles sexuels chez la femme
JP2009541443A (ja) 2006-06-30 2009-11-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 尿失禁及び関連疾患の治療のためのフリバンセリン
EP2054041A2 (fr) 2006-08-14 2009-05-06 Boehringer Ingelheim International GmbH Formulations de flibansérine et leur procédé de fabrication
CL2007002214A1 (es) 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
IL197129A (en) 2006-08-25 2014-08-31 Boehringer Ingelheim Int Controlled release system and method for production
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
CA2686480A1 (fr) 2008-12-15 2010-06-15 Boehringer Ingelheim International Gmbh Nouveaux sels
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a

Also Published As

Publication number Publication date
FI791926A7 (fi) 1979-12-21
NO792020L (no) 1979-12-21
GR67646B (fr) 1981-09-01
DK251079A (da) 1979-12-21
PT69775A (fr) 1979-07-01
AU521110B2 (en) 1982-03-18
IT1121588B (it) 1986-04-02
GB2023594B (en) 1982-10-13
IL57569A0 (en) 1979-10-31
AU4811279A (en) 1980-02-07
ES481632A1 (es) 1980-02-16
GB2023594A (en) 1980-01-03
NZ190758A (en) 1980-10-24
IT7923695A0 (it) 1979-06-18
DE2924681A1 (de) 1980-01-10
SE7905402L (sv) 1979-12-21
LU81396A1 (fr) 1981-02-03

Similar Documents

Publication Publication Date Title
NL7904755A (nl) Fenylpiperazinederivaten, werkwijze ter bereiding hiervan en toepassing van dit derivaat in een farma- ceutisch middel.
NL7512239A (nl) Vast antitranspiratiemiddel, alsmede werkwijze ter bereiding van dit middel.
NL7707129A (nl) Werkwijze ter bereiding van nieuwe cefalospori- nederivaten, werkwijze ter bereiding van far- maceutische preparaten en aldus verkregen ge- vormde preparaten.
NL192603B (nl) Cosmetisch product en werkwijze ter bereiding daarvan.
NL7704057A (nl) Werkwijze ter bereiding van nieuwe cefolosporine- derivaten, werkwijze ter bereiding van farmaceu- tische preparaten en gevormde farmaceutische preparaten.
NL182812B (nl) Werkwijze ter bereiding van polyurethanurea, alsmede gevormd voortbrengsel, vervaardigd onder toepassing daarvan.
NL7903421A (nl) N-gesubstitueerde moranolinederivaten, werkwijze voor de bereiding van een geneesmiddel daaruit en aldus verkregen geneesmiddel.
NL7903048A (nl) Werkwijze ter bereiding van een geneesmiddel tegen kanker, het aldus gevormde geneesmiddel en werkwijze ter bereiding van de geneeskrachtige platina-cooerdina- tieverbindingen.
NL171058C (nl) Werkwijze ter bereiding respectievelijk vervaardiging van een farmaceutisch preparaat met anti-allergische werking en werkwijze ter bereiding van hierbij bruikbare alkoxychinoline-derivaten.
NL7804230A (nl) N-alkyl-n-acylderivaten van thienamycine, werkwijze ter bereiding daarvan, alsmede farmaceutische preparaten.
IT7925621A0 (it) Cefem derivati e procedimento per la loro preparazione.
NL188495C (nl) Bereiding van een proteine voedingsprodukt.
NL184684C (nl) Chloorambucilderivaten met een anti-tumor aktiviteit en werkwijze ter bereiding van een geneesmiddel op basis van deze chloorambucilderivaten.
NL7601803A (nl) Werkwijze ter bereiding van aminobutanolen en derivaten daarvan.
NL7708659A (nl) Werkwijze ter bereiding van 1-azolyl-4-hydroxy- -butaanderivaten, en werkwijze ter bereiding van fungiciden en bactericiden daarmee.
NL7701782A (nl) Bereidingswijze van o-aminofenylketonderivaten.
IL51316A (en) 1-diphenylmethyl-3-hydroxybenzyl piperazine derivatives,method for their preparation and pharmaceutical compositionscontaining them
NL7901787A (nl) Tweefasen pigment en werkwijze ter bereiding van dit pigment.
NL7903047A (nl) Werkwijze ter bereiding van een geneesmiddel tegen kanker, het aldus gevormde geneesmiddel en werkwijze ter bereiding van de geneeskrachtige platina-cooerdina- tieverbindingen.
NL179053C (nl) N-gesubstitueerde moranolinederivaten, werkwijze voor de bereiding ervan, alsmede werkwijze voor de bereiding van een geneesmiddel met een dergelijk derivaat erin.
NL7710325A (nl) Werkwijze ter bereiding van nieuwe chinolinede- rivaten, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL7904750A (nl) Werkwijze ter bereiding van n-alkylbenzothiazolonderi- vaten.
NL7703824A (nl) Werkwijze ter bereiding van nieuwe piperazine- -derivaten, werkwijze ter bereiding van farma- ceutische preparaten, alsmede gevormde farma- ceutische preparaten.
NL7900328A (nl) Derivaten van cyclohexadieen-1-y1-1-butanon, alsmede werkwijze ter bereiding daarvan en werkwijze voor de organoleptische toepassing daarvan.
NL7711272A (nl) Werkwijze ter bereiding van farmaceutische pre- paraten, alsmede gevormde farmaceutische prepa- raten.

Legal Events

Date Code Title Description
BV The patent application has lapsed